Cancers (Jan 2024)

HuR (ELAVL1) Stabilizes <i>SOX9</i> mRNA and Promotes Migration and Invasion in Breast Cancer Cells

  • Jesús Morillo-Bernal,
  • Patricia Pizarro-García,
  • Gema Moreno-Bueno,
  • Amparo Cano,
  • María J. Mazón,
  • Pilar Eraso,
  • Francisco Portillo

DOI
https://doi.org/10.3390/cancers16020384
Journal volume & issue
Vol. 16, no. 2
p. 384

Abstract

Read online

RNA-binding proteins play diverse roles in cancer, influencing various facets of the disease, including proliferation, apoptosis, angiogenesis, senescence, invasion, epithelial–mesenchymal transition (EMT), and metastasis. HuR, a known RBP, is recognized for stabilizing mRNAs containing AU-rich elements (AREs), although its complete repertoire of mRNA targets remains undefined. Through a bioinformatics analysis of the gene expression profile of the Hs578T basal-like triple-negative breast cancer cell line with silenced HuR, we have identified SOX9 as a potential HuR-regulated target. SOX9 is a transcription factor involved in promoting EMT, metastasis, survival, and the maintenance of cancer stem cells (CSCs) in triple-negative breast cancer. Ribonucleoprotein immunoprecipitation assays confirm a direct interaction between HuR and SOX9 mRNA. The half-life of SOX9 mRNA and the levels of SOX9 protein decreased in cells lacking HuR. Cells silenced for HuR exhibit reduced migration and invasion compared to control cells, a phenotype similar to that described for SOX9-silenced cells.

Keywords